Dr. Bo Rode Hansen explains why he joined LIfT as a Non-Executive Director

Alex Blyth, CEO
Mar 5, 2024
1 min read

Updated: May 15, 2024

We recently caught up with Dr. Bo Rode Hansen, a Non-Executive Director at LIfT, to find out what motivated him to join LIfT and why he thinks our platform could make a real difference for patients with cancer.

Recent Posts

See All

LIfT BioSciences joins Bayer Co.Lab Cambridge, securing access to cutting-edge lab facilities

Our Chairman Tony de Fougerolles discusses innate immune rejuvenation

LIfT BioSciences presents preclinical data on its first-in-class Immunomodulatory Alpha Neutrophils at American Society of Gene & Cell Therapy 28th Annual Meeting

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.

Comments

Stay up-to-date with our progress and latest news